Market Cap (In GBp)
13.08 Million
Revenue (In GBp)
75 Thousand
Net Income (In GBp)
-7.14 Million
Avg. Volume
124.47 Thousand
- Currency
- GBp
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 11.0-122.5
- PE
- -
- EPS
- -
- Beta Value
- -0.255
- ISIN
- GB00BDQYGP38
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. James Gareth Short
- Employee Count
- -
- Website
- https://www.celadonpharma.co.uk
- Ipo Date
- 2022-03-31
- Details
- Celadon Pharmaceuticals Plc, a pharmaceutical company, engages in the research, manufacture, and supply of cannabinoids for use in approved medicines. The company focuses on growing indoor hydroponic THC cannabis for use in medicinal products used to treat chronic pain. It also intends to conduct research into cannabinoids for use in chronic pain, as well as other conditions, such as autism and multiple sclerosis. The company was founded in 2018 and is headquartered in London, the United Kingdom.
More Stocks
-
TRUL
-
HMAAGROHMA Agro Industries Limited
HMAAGRO
-
7525Rix Corporation
7525
-
FDCFF
-
MTZMasTec, Inc.
MTZ
-
CAMPUSCampus Activewear Limited
CAMPUS
-
SHALIWIRShalimar Wires Industries Limited
SHALIWIR
-
SUPRAPFSLSupra Pacific Financial Servic
SUPRAPFSL